Santé Ventures
Biotech Investor · 4 portfolio companies
Portfolio
4
Focus Areas
13
Top Stage
First-in-Human / Early Feasibility
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| VS3 Medical | — |
| Libra Therapeutics | — |
| Solu Therapeutics | — |
| Glyscend Therapeutics | — |